E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers A > Headlines for Alto Neuroscience Inc. > News item
Published on 1/30/2023 in the Prospect News Private Placement Daily.

Alto Neuroscience borrows up to $35 million from K2 HealthVentures

Chicago, Jan. 30 – Alto Neuroscience Inc. announced $60 million in additional financing that includes up to $35 million from a credit facility with K2 HealthVentures, according to a press release.

Proceeds will be used for the company’s clinical-stage pipeline.

The other part of the $60 million came from a $25 million series B funding.

In total, Alto has raised $100 million since the company was founded in 2019.

Based in Los Altos, Calif., Alto develops targeted medicines for precision psychiatry.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.